𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression profile of genes involved in pathogenesis of pediatric Crohn's disease

✍ Scribed by Winnie H Sim; Josef Wagner; Donald J Cameron; Anthony G Catto-Smith; Ruth F Bishop; Carl D Kirkwood

Book ID
115171054
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
275 KB
Volume
27
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Profile of pediatric Crohn's disease in
Profile of pediatric Crohn's disease in Belgium
✍ De Greef, E.; Mahachie John, J.M.; Hoffman, I.; Smets, F.; Van Biervliet, S.; Sc πŸ“‚ Article πŸ“… 2013 πŸ› Oxford University Press 🌐 English βš– 437 KB
Characterization of intestinal gene expr
Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis
✍ Colin L. Noble; Alexander R. Abbas; Charles W. Lees; Jennine Cornelius; Karen To πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 484 KB

Background: Genome-wide microarray expression analysis creates a comprehensive picture of gene expression at the cellular level. The aim of this study was to investigate differential intestinal gene expression in patients with Crohn's disease (CD) and controls with subanalysis of confirmed CD suscep

Predictive value of epithelial gene expr
Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease
✍ Ingrid Arijs; Roel Quintens; Leentje Van Lommel; Kristel Van Steen; Gert De Hert πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 432 KB

Background: Infliximab (IFX) has become the mainstay of therapy of refractory Crohn's disease (CD). However, a subset of patients shows incomplete or no response to this agent. In this study we investigated whether we could identify a mucosal gene panel to predict (non)response to IFX in CD. Method